It seems as if Medtronic’s announcement yesterday with the launch of the InPen connected to the Medtronic CGM has created some controversy. Now before we get into this let’s be very clear here this system is NOT yet a full-blown Tyler. It is a first step towards a Tyler, a baby step but a first step, nonetheless. Let’s also acknowledge the obvious right now there is only ONE CGM system that is approved to be used for making insulin dosing decisions, the G6 from Dexcom. Let’s further acknowledge what everyone also knows while . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.